Cytiva Cell and Gene Webinars and Podcasts

1. Elevating AAV Manufacturing WithTailored Cell Lines 9/19/2024

   Skillfully crafted cell lines can substantially enhance vector purity and yield. Watch to explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.

2. Process Development Optimization For GMP CAR-T Manufacturing 4/17/2024

   Explore the significance of process development optimization and key considerations including selecting an outsourcing partner for PD projects, timing, technology, and process transfer, among others.

3. Bridging The Distance To Large-Scale GMP Manufacturing Of Viral Vectors 10/26/2023

   AGC Biologics discusses its journey to the successful implementation of iCELLis™ bioreactors in their AAV and lentivirus platforms.

4. Analyzing Full And Empty AAV Capsid Ratio – In Less Than 5 Minutes 10/24/2023

   Presenters show how Capto Q run on an ÄKTA pure 25 chromatography system can be used to determine the percentage of full capsids of AAV8 and AAV9 with low sample consumption.

5. Cell Therapy Milestones, Challenges, And Forming The Future Of TILs 8/15/2023

   What enabled the evolution of TIL therapies? What does the future hold for them? And where should you concentrate your efforts to accelerate progress? Watch for answers to these questions and more.

6. Capabilities And Opportunities Of Innovative Cell Processing System In CGT 8/15/2023

   Discover a system that can automate several steps of your cell therapy workflow while achieving high efficiency, how to optimize cell recovery during harvesting, and more.

7. 3 Things To Consider For Capacity Expansion 6/2/2022

   In this panel discussion, you’ll learn from experienced colleagues who share their approaches to capacity expansion and offer tips for your success.

8. Cryopreservation's Impact On Cell Therapy Consistency, Quality 1/12/2022

   Explore the underpinning mechanisms driving freeze/thaw applications and their implications across varied drug product containment configurations and volumes.

9. Accelerate The Development & Production Of Viral-Based Gene Therapies 11/23/2021

   The recent pandemic revealed that with the proper framework, a drug product can be developed, clinically tested, and produced for hundreds of millions of patients in less than a year. 

10. Validation Of Integrated Cryogenic Systems For Cell Therapy Manufacturing 4/13/2021

    Amittha Wickrema, Ph.D., Professor of Medicine, Director, Advanced Cellular Therapeutics Facility, University of Chicago, reviews the cold chain workflow from start to finish for a cellular therapy product.